Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 219,937,497 papers from all fields of science
Search
Sign In
Create Free Account
testosterone 6-beta-hydroxylase activity
Known as:
testosterone 6b-hydroxylase activity
Catalysis of the reaction: testosterone + donor-H2 + O2 = 6-beta-hydroxytestosterone + H2O. [GOC:ai, PMID:11726664]
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Modulation of P 450 CYP 3 A 4-Dependent Metabolism by P-glycoprotein : Implications for P 450 Phenotyping
J. Baron
,
L. Goh
,
D. Yao
,
C. Wolf
,
T. Friedberg
2001
Corpus ID: 6786623
Some compounds used for phenotyping of cytochrome P450s are substrates of P-glycoprotein (pgp). It is likely that in these cases…
Expand
2000
2000
OF HUMAN CYP 3 A 4 USING A SPECIFIC PROINHIBITORY ANTIPEPTIDE ANTIBODY
T. Schulz-Utermoehl
,
R. Mountfield
,
R. Bywater
,
K. Madsen
,
P. N. JØrgensen
,
K. Hansen
2000
Corpus ID: 863912
An anti-peptide antibody targeted against residues 253 to 269 of human CYP3A4 was produced that specifically and potently…
Expand
1999
1999
MODULATION OF HEPATIC CYP 2 A 1 , CYP 2 C 11 , AND CYP 3 A 9 EXPRESSION IN ADULT RATS BY NEONATAL ADMINISTRATION OF TAMOXIFEN
M. Kawai
,
S. Bandiera
,
Thomas K. H. Chang
,
F. Poulet
,
P. Vancutsem
,
G. Bellward
1999
Corpus ID: 8089947
To examine the effect of neonatal administration of tamoxifen on adult expression of hepatic cytochrome P-450 (CYP) enzymes and…
Expand
1997
1997
In vitro metabolism of indinavir in the human fetal liver microsomes.
M. Chiba
,
J. A. Nshime
,
J. Lin
Drug Metabolism And Disposition
1997
Corpus ID: 7564616
In vitro microsomal formation of primary metabolites of indinavir (CRIXIVAN, MK-0639, L-735,524), an HIV protease inhibitor, were…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE